KOSDAQ · Healthcare · ₩132B
₩2,835-1.90%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.9% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“신약 후보를 넓히는 단계라 개발 진전이 핵심이에요.”
In the company's words · 2026 2분기 filing